Dr Michael Laurence Able, MD | |
786 D Street, Joint Base Elmendorf-richardson, AK 99505 | |
(209) 602-7785 | |
Not Available |
Full Name | Dr Michael Laurence Able |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 786 D Street, Joint Base Elmendorf-richardson, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417415332 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | MD-21728 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael Laurence Able, MD 1 Headquarters Loop, Joint Base Elmendorf-richardson, AK 99506 Ph: () - | Dr Michael Laurence Able, MD 786 D Street, Joint Base Elmendorf-richardson, AK 99505 Ph: (209) 602-7785 |
News Archive
Verizon Wireless today announced an initiative with BL Healthcare and a number of customers and third-party providers to jointly trial next-generation solutions for the delivery of remote healthcare applications and services to patients. This initiative will provide a unique approach for addressing issues associated with access to quality healthcare and rising healthcare costs.
Neogenix Oncology announced today that it has filed a patent application with the US Patent and Trade Office for the NPC-1C antigen. This antigen appears to be tumor specific for pancreatic and colorectal tumors.
The Society of Chest Pain Centers (www.SCPCP.org), an international non-profit focused on improving care for cardiac patients, has announced that Yale - New Haven Hospital has earned the SCPC accreditation in recognition of its ability to quickly determine and intervene when a patient is experiencing cardiac symptoms.
Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery. Those are the key findings of a multi-centre study of nearly 600 patients published in the April issue of the urology journal BJUI.
The evidence that circulating levels of markers of bone turnover correlate with hip fracture risk among postmenopausal women is limited.
› Verified 5 days ago